Harding Loevner’s ResMed RMD Stock Holding History

Harding Loevner’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-81	Closed	-$18K	–	144
2022 Q3	$18K	Hold	81	–	–	﹤0.01%	131
2022 Q2	$17K	Hold	81	–	–	﹤0.01%	136
2022 Q1	$16K	Hold	81	–	–	﹤0.01%	138
2021 Q4	$21K	Hold	81	–	–	﹤0.01%	141
2021 Q3	$21K	Hold	81	–	–	﹤0.01%	127
2021 Q2	$20K	Hold	81	–	–	﹤0.01%	131
2021 Q1	$16K	Hold	81	–	–	﹤0.01%	144
2020 Q4	$17K	Hold	81	–	–	﹤0.01%	133
2020 Q3	$14K	Hold	81	–	–	﹤0.01%	166
2020 Q2	$16K	Hold	81	–	–	﹤0.01%	125
2020 Q1	$12K	Sell	81 -429	-84%	-$68.3K	﹤0.01%	132
2019 Q4	$79K	Hold	510	–	–	﹤0.01%	95
2019 Q3	$69K	Sell	510 -162	-24%	-$21.2K	﹤0.01%	90
2019 Q2	$82K	Hold	672	–	–	﹤0.01%	88
2019 Q1	$70K	Buy	+672	New	+$69.4K	﹤0.01%	90

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Harding Loevner's RMD Position: Q4 2022 in Review

Harding Loevner sold out of ResMed (RMD) in Q4 2022, closing a stake of 81 shares — an estimated $18K sold.

Harding Loevner first reported a position in RMD in Q1 2019 and held it in 15 quarters. The position peaked at $82K in Q2 2019. 730 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

Harding Loevner reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
Harding Loevner sold 81 ResMed shares in Q4 2022, an estimated $18K.
Harding Loevner first reported a position in ResMed in Q1 2019 and held it in 15 quarters.
Harding Loevner's ResMed position peaked at $82K in Q2 2019.
730 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Harding Loevner's 13F filing for Q4 2022, filed 14 Feb 2023.